China Resources Medical Holdings Company Limited provided consolidated earnings guidance for the six months ended June 30, 2023. For the period, the company expects profit for the period attributable to owners of the parent company of the Group as contained in the consolidated financial statements for the Reporting Period would increase by approximately 60% as compared with the restated figures for the corresponding period in year 2022. The increase was mainly attributable to the consolidation arrangement regarding the LH Subjects and the JE Subject where the Group will retrospectively consolidate the financial results of the LH Subjects and the JE.